CytoGen (Laboratory Service) is Laboratory Services (Healthcare) in South Korea that focus on Liquid Biopsy Platforms business. Founded in 2010. They cover business area such as Cytogen Inc, hd microporous chip, microfluidic, nanotechnology, viable CTCS, tumor cell, cancer patient blood, two business area, Liquid Biopsy Applications, Liquid Biopsy Platforms.
Laboratory Services (Healthcare)
2010
( 14 years old in 2024 )
Liquid Biopsy Platforms
-
A-8F, SK V1 GL Metrocity, 128
Beobwon-ro, Songpa-gu
Seoul, 05854
South Korea
Private
Cytogen Inchd microporous chipmicrofluidicnanotechnologyviable CTCStumor cellcancer patient bloodtwo business areaLiquid Biopsy ApplicationsLiquid Biopsy Platforms
* We use standard office opening hours in near CytoGen (Laboratory Service)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
CytoGen (Laboratory Service) is Laboratory Services (Healthcare) business from South Korea that founded in 2010 (14 years old in 2024), CytoGen (Laboratory Service) business is focusing on Liquid Biopsy Platforms.
CytoGen (Laboratory Service) headquarter office and corporate office address is located in A-8F, SK V1 GL Metrocity, 128 Beobwon-ro, Songpa-gu Seoul, 05854 South Korea.
CytoGen (Laboratory Service) was founded in South Korea.
In 2024, CytoGen (Laboratory Service) is currently focus on Liquid Biopsy Platforms sector.
Above is snippet of Google Trends for "Liquid Biopsy Platforms" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with CytoGen (Laboratory Service), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
